Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3200 SW 60 Court #302
Suite 302
Miami, FL 33155Phone+1 305-662-8330Fax+1 305-663-2813
Education & Training
Nicklaus Children's Hospital/Cleveland Clinic FoundationFellowship, Clinical Neurophysiology, 2006 - 2007
University of WashingtonFellowship, Child Neurology, 2003 - 2006
University of Utah HealthResidency, Pediatrics, 2001 - 2003
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2001
Certifications & Licensure
CO State Medical License 2023 - 2025
FL State Medical License 2007 - 2024- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Epilepsy
Clinical Trials
- A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures Start of enrollment: 2013 Apr 29
- GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome Start of enrollment: 2015 Apr 13
- Treatment of Drug Resistant Epilepsy
- Join now to see all
Publications & Presentations
PubMed
- 583 citationsCannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trialOrrin Devinsky, Eric D. Marsh, Daniel Friedman, Elizabeth A. Thiele, Linda Laux
The Lancet. Neurology. 2016-03-01 - 151 citationsDose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial.Ian Miller, Ingrid E. Scheffer, Boudewijn Gunning, Rocío Sánchez-Carpintero, Antonio Gil-Nagel
JAMA Neurology. 2020-05-01 - 8 citationsEarly Implantation as a Main Predictor of Response to Vagus Nerve Stimulation in Childhood-Onset Refractory Epilepsy.Angelo Russo, Ann Hyslop, Valentina Gentile, Daniela Chiarello, Tullio Messana
Journal of Child Neurology. 2021-04-01
Journal Articles
- Biallelic Loss of Human CTNNA2, Encoding αN-Catenin, Leads to ARP2/3 Complex Overactivity and Disordered Cortical Neuronal MigrationJoseph G Gleeson, Ian Miller, Bruce A Barshop, William B Dobyns, Murat Gunel, Nature
Press Mentions
Epidemiology: Mapping COVID-19 Disease Burden Across the USAJune 16th, 2020
Princeton Researchers Map Rural U.S. Counties Most Vulnerable to COVID-19April 16th, 2020
Cannabis-Based Drug Reduces Hard-to-Treat Epilepsy in Children by 50 PercentMay 6th, 2019- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
